Our research and trials staff are dedicated and experienced professionals, interested in pushing the boundaries of our knowledge and testing new ideas in practical environments. Use the links below to jump to categorised trials.
| SPIRIT2 | |
| Type: | NCRI, multi-centre phase III randomised trial |
| Eligibility: | Newly diagnosed CML in chronic phase Age >18 years |
| Study details: | Compares Imatinib 400 vs Dasatanib 100 |
